NEWS
Fighting the pandemic of antimicrobial resistance
AdjuTec Pharma is preparing the company’s first clinical trial.
ECHOS gathers Europe against cancer
An international cancer collaboration aims to improve the lives of 3 million people.
Harnessing AI for cancer prevention and treatment
A new project proposes to use AI to improve cancer care in Norway.
Summer vibes in our house
The annual summer gathering brought together colleagues in the Norwegian oncology field.
Geir Hetland joins the board of Oslo Cancer Cluster
The Chief Financial Officer of Thermo Fisher Scientific is the newest board member.
Home testing to improve cancer prevention
Can home tests engage more people in cancer screening and save more lives?
Cell therapy breakthroughs in cancer treatment
The Translational Research Unit at the Section for Cellular Therapy based in Norway recently published two groundbreaking studies showcasing the potential of cell-based therapies in combating cancer.
Lytix and Curida: Growth and innovation
Lytix Biopharma and Curida, both Norwegian-owned, have gained attention and acclaim for their innovative approaches and substantial contributions to the healthcare sector.
Oslo Cancer Cluster Sammen om superklynge
De fire helseklyngene gikk denne uka sammen om et høringsinnspill til Stortinget.
